DaVita Inc. (DVA) is a publicly traded Healthcare sector company. As of November 10, 2026, DVA trades at $179.16 with a market cap of $12.04B and a P/E ratio of 14.63. DVA moved -3.41% today. Year to date, DVA is +61.95%; over the trailing twelve months it is +49.93%. Its 52-week range spans $101.00 to $247.49. Analyst consensus is neutral with an average price target of $225.20. Rallies surfaces DVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover DVA: 0 strong buy, 2 buy, 2 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $225.20.
| Metric | Value |
|---|---|
| Price | $179.16 |
| Market Cap | $12.04B |
| P/E Ratio | 14.63 |
| EPS | $12.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $247.49 |
| 52-Week Low | $101.00 |
| Volume | 469.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.01B |
| Net Income | $1.19B |
| Gross Margin | 0.00% |
5 analysts cover DVA: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $225.20.